ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,951, issued on Nov. 4, was assigned to SHY Therapeutics LLC (Harrison, N.Y.).

"Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease" was invented by Yaron R. Hadari (Harrison, N.Y.), Michael Schmertzler (St. Petersburg, Fla.), Theresa M. Williams (Harleysville, Pa.), Carolina Bigarella (Pleasantville, N.Y.), Luca Carta (Scarsdale, N.Y.), Rebecca Hutcheson (Stamford, Conn.), Sufang Zhang (Briarcliff Manor, N.Y.) and Charles H Reynolds (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula I, or a pharmaceutically acceptab...